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Abstract
Background: Examine interactive relations of race and poverty status with cardiovascular disease (CVD) risk factors
in a socioeconomically diverse sample of urban-dwelling African American (AA) and White adults.
Methods: Participants were 2,270 AAs and Whites (57 % AA; 57 % female; ages 30–64 years) who completed the
first wave of the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study. CVD risk factors
assessed included body mass index (BMI), waist circumference (WC), total cholesterol (TC), high- and low-density
lipoprotein cholesterol (HDL-C, LDL-C), triglycerides (TG), glycated hemoglobin (HbA1c), high-sensitivity C-reactive
protein (CRP), and systolic, diastolic, and pulse pressure (SBP, DBP, PP). Interactive and independent relations of race,
poverty status, and sex were examined for each outcome via ordinary least squares regression adjusted for age,
education, literacy, substance use, depressive symptoms, perceived health care barriers, medical co-morbidities, and
medications.
Results: Significant interactions of race and poverty status (p’s < .05) indicated that AAs living in poverty had lower
BMI and WC and higher HDL-C than non-poverty AAs, whereas Whites living in poverty had higher BMI and WC
and lower HDL-C than non-poverty Whites. Main effects of race revealed that AAs had higher levels of HbA1c, SBP,
and PP, and Whites had higher levels of TC, LDL-C and TG (p’s < .05).
Conclusion: Poverty status moderated race differences for BMI, WC, and HDL-C, conveying increased risk among
Whites living in poverty, but reduced risk in their AA counterparts. Race differences for six additional risk factors
withstood extensive statistical adjustments including SES indicators.
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Background
Pronounced disparities associated with race and socio-
economic status (SES) are well documented with respect
to cardiovascular disease (CVD) morbidity and mortality
[1, 2]. In the United States, race-related disparities are
most pronounced for African Americans (AAs) - associ-
ations that are thought to be partially [3] though not
completely, accounted for by SES [2]. SES bears similarly
potent relations to CVD morbidity and mortality that
are not fully explained by race [4]. Race- and SES- re-
lated disparities in CVD morbidity and mortality may be
partially attributed to differential burden of cardiovascu-
lar risk factors (e.g., hypertension, diabetes) including
their frequency, severity, and/or control [5, 6].
It has long been emphasized that dual consideration
must be given to race and SES within the context of
health disparities research [2, 7]. Yet, disaggregating
their respective influences has proven a challenging (and
perhaps impossible) task. Williams and colleagues [7]
suggest the need to explicitly examine the interaction of
race and SES with respect to health outcomes to better
understand their combined influence. Prior investiga-
tions have indeed noted significant interactive relations
of race and SES to CVD risk profiles. In that regard, re-
sults of multiple investigations have shown associations
of higher SES (e.g., education, income) with better CVD
outcomes such as coronary heart disease, subclinical
atherosclerosis, overweight and obesity, and various
measures of inflammation in Whites but not Blacks [8–
10].
It has further been noted that race- and SES-related
disparities in CVD risk factors vary by sex [2]. For in-
stance, higher levels of education have been associated
with a poorer lipid profile in Black men, but a better
profile in Black women [11]. In addition, Boykin and col-
leagues noted that lower SES was associated with greater
hypertension, diabetes, body mass index, and smoking in
Whites and in Black women, but findings were incon-
sistent for Black men [12].
Further investigation of race and SES interactions with
respect to CVD risk is warranted for several reasons.
First, a common challenge associated with work in this
area is that the AA samples generally have a lower aver-
age SES than the White samples. Indeed, least common
are samples that include lower SES, urban Whites. Fur-
thermore, samples with a full spectrum of SES often fo-
cused solely on a single sex and/or racial group. Next,
few studies of race by SES interactions have examined a
broad CVD risk profile. Lastly, three way interactions of
race, SES, and sex should be explicitly examined.
Accordingly, the present study aimed to extend prior
work in this area by describing the interactive relations of
race, poverty status, and/or sex with a series of anthropo-
metric, metabolic, inflammatory, and hemodynamic CVD
risk factors in a large sample of AA and White women
and men of diverse SES following adjustment for a multi-
tude of variables that may confound or partially mediate
these associations- age, education, literacy, smoking, alco-
hol, and illicit drug use, depressive symptomatology, per-




Data were derived from the Healthy Aging in Neigh-
borhoods of Diversity across the Lifespan (HANDLS)
study - an epidemiological investigation uniquely de-
signed to disentangle respective influences of race and
SES, as indexed by poverty status, on a broad spectrum
of age-related risk and disease outcomes including
CVD risk factors [13]. The present participants were
1,301 AA and 969 White men and women who com-
pleted the first wave of the HANDLS study between
2004 and 2009. Participants were recruited from thir-
teen neighborhoods in Baltimore, MD, chosen to span
diverse levels of income and socioeconomic status [13].
For HANDLS, approximately equal numbers of partici-
pants were recruited from separate clusters of contigu-
ous census tracts – neighborhoods – containing
sufficient numbers of residents to fill a factorial cross
of sex, race, 5-year age groups, and poverty status
(above or below 125 % of the Federal poverty guide-
lines based on household size). Neighborhoods were
selected based on data from the 2000 census. Households
were selected randomly for potential participation as were
individuals within households. Participants were eligible if
they self-identified as either Black/African American or
White/Caucasian. Recruiters visited 32,959 dwellings in
which they found 14,799 potentially eligible individuals in
9,904 households among whom 8,150 individuals actually
met initial screening criteria. Of these potentially eligible
individuals, 3720 participants met all study inclusion
criteria and none of the following exclusion criteria: 1)
outside of the age range 30–64 years; 2) currently preg-
nant; 3) within 6 months of receiving chemotherapy,
radiation, or biological treatments for cancer; 4) diag-
nosed with AIDS; 5) unable to provide informed con-
sent due to mental incapacity resulting from drug or
alcohol intoxication, severe developmental disability, or
dementia; 6) unable to provide at least five data mea-
sures on the mobile medical research vehicle (MRV); 7)
without a verifiable address at time of consent, or lack
of valid government issued identification; and 8) pres-
ence of uncontrolled high blood pressure (> 160/100).
Seventy-eight percent of all eligible and non-excluded
individuals agreed to participate in the first wave of the
HANDLS study.
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Of the 3,720 persons who completed a detailed initial
interview in their home (study phase I), 2,707 returned
to engage in a subsequent assessment on the MRV
(study phase II).The present analyses targeted those
2,707 participants who had completed both phases of
the HANDLS protocol (described in further detail
below). We further excluded persons with a history of
stroke (n = 60), dementia (n = 4), or other neurological
disease (n = 105), heart failure (n = 60), HIV infection
(n = 64), schizophrenia (n = 29), kidney disease or dialy-
sis (n = 70), and those with missing data for key pre-
dictor variables (e.g., sociodeomgraphics; n = 142), An
additional 150 individuals were excluded for providing
a non-fasting sample for blood-based outcomes, and
215 persons were missing C-reactive protein (CRP). Imput-
ation was performed for all outcome variables with < 10 %
missing within each race, poverty status and sex sub-
group (i.e., SBP, DBP, PP, BMI, WC, TC, LDL-C, HDL-
C, TG). Multiple regression analysis (using age, sex,
race, and poverty status as predictors) was used for
imputation for the purpose of replicability. The final
samples sizes for each outcome variable (after associ-
ated exclusions and increase in sample size following
imputation) were: n = 2270 for SBP, DBP, PP, BMI, WC,
TC, LDL-C, HDL-C, and TC; n = 2134 for HbA1c; and
n = 2069 for CRP.
Phase I of the HANDLS protocol was administered in
participants' homes and included screening, recruitment,
informed consent, and administration of an interview
concerning various sociodemographic factors, neighbor-
hood characteristics, health care utilization and others.
Phase II was conducted on MRVs parked in participants'
neighborhoods. This visit consisted of a medical history,
physical examination, laboratory measurements, cogni-
tive testing, and other diagnostic procedures. All partici-
pants provided written informed consent. The study
protocol was approved by the Institutional Review Board
at the National Institute of Environmental Health Sci-
ences. Participants were compensated $100 upon com-
pletion of phase II testing. HANDLS study data are
available via formal request; see http://handls.nih.gov for
associated form and application procedures.
Measures
Demographic variables
Demographic characteristics included age (in years), sex
(0 = female; 1 =male), self-identified race (0 =White; 1 =
AA), and education (highest grade completed in school).
Poverty status was predicated on size of household and
reported family income relative to the 2004 Federal pov-
erty threshold (e.g. $18,850 per year for a family of 4).
Poverty status was defined as below 125 % of the poverty
threshold (due to cost of living in Baltimore, MD), and
non-poverty was defined as family income at or above
125 % of the poverty threshold. These data were dichot-
omized as 0 = not poverty and 1 = poverty. Poverty status
was used as one of the primary selection criteria for
HANDLS because pilot testing revealed that participants
were better able to reliably report this status as opposed
to a specific annual income.
Behavior/Lifestyle factors
Substance use was queried during the medical history.
Alcohol status was coded as 0 = not current user (i.e.,
never tried, never used regularly, or used > 6 months
ago) or 1 = used within the past 6 months. Smoking sta-
tus was dichotomized as 0 = not current user (i.e., never
tried, never used regularly, or former users) and 1 =
current user. Use of marijuana, cocaine, and opiates was
coded as 0 = not current user, or 1 = used in the past
6 months.
Psychological factors
Depressive symptoms were assessed via the Center for
Epidemiological Studies-Depression scale [14], a 20-item
self-report instrument that has been widely used and vali-
dated in community-based epidemiological studies. The
reading subtest of the Wide Range Achievement Test –
3rd Edition [15] was used as an estimate of literacy.
Healthcare barriers
Questionnaire items reflecting barriers to healthcare in-
cluded access to specialty care, ability to get an ap-
pointment, expense, language differences, anxiety/fear,
waiting too long, transportation, and excessive paper-
work. Participants rated each as follows: 1 = major
problem; 2 = minor problem, 3 = not a problem. Re-
sponses were reverse coded such that higher response
value indicated greater problem; responses to all items
were then summed.
Anthropometric measures
Height and weight were obtained using calibrated equip-
ment, and BMI was computed as weight divided by
height-squared (kg/m2). Waist circumference (WC) was
measured to the nearest 0.1 cm with a flexible tape
measure placed at the midpoint between the lower rib
margin and the iliac crest at the end of exhalation during
normal breathing.
Metabolic and inflammatory measures
Blood samples were obtained from an antecubital vein
following an overnight fast. Levels of total serum chol-
esterol (TC), low and high density lipoprotein choles-
terol (LDL-C; HDL-C), triglycerides (TG), and glycated
hemoglobin (HbA1c) were assessed by standard labora-
tory methods at Quest Diagnostics (Chantilly, VA;
http://www.questdiagnostics.com). TC, HDL-C, and
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TG were derived spectrophotometrically and LDL-C
was calculated from HDL-C and TC. HbA1c was
assessed via high performance liquid chromatography.
All laboratory testing measures met or exceeded the
standards set by Clinical Laboratory Improvement
Amendments 1988, the U.S. Centers for Disease Con-
trol, and the Prevention-National Heart, Lung and
Blood Institute Lipid Standardization Program guide-
lines with total allowable error (random and systemic)
on a single result ranging from ≤ 8.9 % for TC to ≤ 15 %
for TG. High sensitivity CRP levels were measured
from blood samples by immunoassay at the National
Institutes of Aging or Quest Diagnostics using similar
equipment and reagents.
Hemodynamic measures
Systolic and diastolic blood pressure (SBP, DBP) were
assessed using a standard brachial artery auscultation
method following a 5 min rest in a seated position. Mea-
sures were obtained with the arm at a 90-degree angle,
palm facing up. One measure was obtained in each arm;
those measures were averaged. Pulse pressure was calcu-
lated by subtracting the mean of DBP from the mean of
SBP.
Comorbidities
During the MRV visit, a HANDLS physician or nurse
practitioner performed a comprehensive physical exam-
ination and medical history. The evaluator documented
as unambiguously as possible any diagnosable medical
conditions and use of medications. For the present ana-
lyses, select medical comorbidities were grouped into
the following clusters: (a) coronary artery disease, myo-
cardial infarction, peripheral artery disease, atrial fibrilla-
tion, angioplasty, carotid endarterectomy, and coronary
artery bypass surgery as a cardiovascular disease (CVD)
group; and (b) other prevalent metabolic/infectious/
autoimmune (MIA) diseases including diabetes mellitus,
thyroid disease, kidney disease, hepatitis, and systemic
lupus erythematosus Medical conditions were dichoto-
mized (0 = not present; 1 = present) and scores were
summed across conditions within clusters.
Data analyses
A series of ordinary least squares regression analyses were
conducted to assess potential independent and interactive
relations of race, poverty status, and sex to each cardiovas-
cular risk factor. Regression models included the interac-
tions of race x poverty status x sex, race x poverty status,
race x sex, and poverty status x sex, in addition to the
first-order terms of race, poverty status, and sex. Adjust-
ment variables included age, use of alcohol, cigarettes,
marijuana, cocaine, or heroine, an estimate of literacy, de-
pressive symptomatology, perceived healthcare barriers,
BMI (except for BMI and WC outcomes),and medical co-
morbidity clusters (CVD and MIA; with diabetes removed
from the MIA cluster for the HbA1c analyses). Medication
use was included in the models as follows: use of antihy-
pertensives, antilipidemics, and diabetes medications was
included for the metabolic and inflammatory outcomes;
antihypertensives were included for all blood pressure out-
comes; and diabetes medications were included for the an-
thropometric outcomes. Distributions of the outcome




Descriptive statistics and frequencies were calculated for
the final sample. See Table 1 for a summary of descrip-
tive statistics in the full sample, and by race and poverty
status.
Regression analyses
There were no significant three-way interactions of race,
poverty status, and sex or two-way interactions of pov-
erty status and sex for any of the CVD risk factors (see
Tables 2, 3 and 4). Results for significant interactions of
race x poverty status and race x sex, and first order
terms of race and poverty status are described below by
conceptually related clusters of risk factors.
Anthropometric measures (BMI, WC)
Results revealed significant interactions between race
and poverty status for BMI and WC (see Table 2 and
Fig. 1). Specifically, non-poverty AAs had greater BMI
and WC than those living in poverty. However, non-
poverty Whites had lower BMI than those living in pov-
erty. Additionally, for those living in poverty, BMI was
higher for Whites than for AAs, whereas BMI was
higher for non-poverty AAs than for non-poverty
Whites. Furthermore, AAs living in poverty had lower
WCs than non-poverty AAs, as well as Whites regard-
less of poverty status.
Significant race by sex interactions were also found for
BMI and WC. Specifically, AA women had greater BMI
than White women, whereas AA men had lower BMI
than White men (see Fig. 2). In addition, White men
had a higher WC than AA men, but there was no differ-
ence in WC between AA and White women
Metabolic and inflammatory measures (TC, LDL-C, HDL-C,
TG, HbA1c, CRP)
Regression analyses for lipid measures showed significant
interactions between race and poverty status for HDL-C,
but not TC, LDL-C, or TG (see Table 3 and Fig. 1). The
interaction between race and poverty status was such that
Whites living in poverty had lower HDL-C levels than
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non-poverty Whites, whereas AAs living in poverty had
higher HDL-C than non-poverty AAs (see Fig. 1). Add-
itionally, the first-order term of race was associated with
TC, LDL-C, and TG, with AAs having lower lipids levels
than Whites for each measure. Interactions of race and
sex, and the first-order term of poverty status were not as-
sociated significantly with any of the lipid measures.
As shown in Table 3, there were no interactive effects
of race and poverty status or race and sex for HbA1c.
There was a significant main effect of race such that
AAs had higher HbA1c than Whites. Poverty status was
not associated with HgbA1c. Additionally, there were no
interactive effects of race and poverty status or race and
sex for CRP. Neither race nor poverty status was signifi-
cantly associated with CRP.
Hemodynamic measures (SBP, DBP, PP)
As shown in Table 4, there were no significant interac-
tions of race and poverty status, or race and sex for SBP,
DBP or PP. There was a significant main effect of race
on SBP and PP such that AAs had higher resting SBP
and PP than Whites. There were no significant main ef-
fects for poverty status for any blood pressure measure.
Discussion
Estimating the respective influences of race and SES on
CVD risk has proven a challenging task. Here we used
data from the HANDLS study to examine potential
interactive relations of race, poverty status, and sex to a
broad spectrum of CVD risk factors within a socioeco-
nomically diverse sample of urban-dwelling AA and









White Non - Poverty
(n = 671)
Age (years) 47.6 (9.3) 46.4 (9.1) 48.4 (9.3) 47.2 (9.5) 48.1 (9.4)
Female (%) 56.5 58.0 55.3 62.4 54.0
African-American (%) 57.3
Below Poverty Line (%) 39.1
Education (years) 12.5 (3.1) 11.7 (2.3) 12.9 (2.7) 11.4 (3.1) 13.4 (3.6)
WRAT-III Read score 42.3 (8.1) 39.4 (8.2) 41.4 (7.1) 41.8 (8.4) 45.9 (7.4)
CES-D score 14.6 (11.2) 16.4 (11.4) 12.6 (10.2) 17.8 (11.8) 13.6 (11.2)
Cigarette Use (%) 45.0 56.1 39.1 56.4 36.5
Alcohol Use (%) 54.9 52.2 55.0 50 59.2
Marijuana Use (%) 12.6 16.1 14.2 9.7 9.2
Cocaine Use (%) 5.3 8.6 4.4 7.1 2.7
Heroin Use (%) 3.2 5.4 2.7 4.2 1.2
CVD Cluster (%) 4.0 4.2 3.5 5.0 3.7
MIA Cluster (%) 23.1 22.5 22.2 27.5 22.5
Antihypertensives (%) 31.0 31.4 35.3 25.8 28.3
Antilipidemics (%) 16.0 11.7 15.1 16.8 20.6
Diabetes Medications (%) 9.3 8.5 10.8 10.1 8.2
Systolic BP (mmHg) 120.5 (17.4) 122.3 (17.9) 121.9 (16.3) 118.5 (19.1) 118.5 (17.0)
Diastolic BP (mmHg) 72.9 (10.6) 73.6 (11.2) 73.2 (10.4) 72.8 (11.2) 72.0 (10.2)
Pulse Pressure (mmHg) 47.6 (12.6) 48.6 (13.0) 48.7 (12.4) 45.7 (12.8) 46.4 (12.2)
Body Mass Index (kg/m2) 30.1 (7.7) 29.2 (8.1) 30.7 (7.4) 30.7 (8.6) 29.90 (7.3)
Waist Circumference (cm) 100.0 (17.5) 95.4 (17.7) 100.9 (16.1) 103.3 (19.0) 101.60 (17.3)
Total Cholesterol (mg/dl) 187.3 (41.9) 182.1 (40.2) 186.3 (42.3) 188.8 (43.5) 192.2 (41.6)
HDL-Cholesterol (mg/dl) 53.0 (17.0) 57.1 (19.8) 54.7 (16.8) 47.3 (13.6) 50.20 (14.6)
LDL-Cholesterol (mg/dl) 109.6 (35.3) 104.7 (35.9) 109.9 (35.0) 110.0 (34.7) 113.20 (34.75)
Triglycerides (mg/dl) 127.2 (125.3) 102.0 (55.8) 109.6 (83.7) 172.3 (244.5) 147.90 (119.7)
Glycated Hemoglobin (%) 6.0 (1.3) 6.1 (1.4) 6.1 (1.2) 5.9 (1.2) 5.80 (1.1)
C-Reactive Protein (mg/l) 4.8 (9.6) 5.7 (14.9) 4.6 (7.3) 4.8 (5.8) 4.30 (7.3)
Means and standard deviations unless otherwise stated. AA = African American; WRAT =Wide Range Achievement Test; CES-D = Center for Epidemiologic Studies
Depression Scale; CVD = self-reported cardiovascular disease; MIA = self-reported metabolic/inflammatory/autoimmune disease; BP = blood pressure; HDL = high
density lipoprotein; LDL = low density lipoprotein
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White adults. Results revealed synergistic associations of
race and poverty status for BMI, WC, and HDL-C.
Whereas Whites living in poverty had greater BMI and
WC than non-poverty Whites, AAs living in poverty had
lower BMI and WC and greater HDL-C as compared to
non-poverty AAs.
Although prior research with these outcome measures
has more typically used education as the primary SES in-
dicator, associated findings are similar to our own. For
example, in contrast to White women, higher levels of
education did not protect against the development of
overweight and obesity among AA women [10]. This
“lack of protection” from higher SES with respect to
BMI has also been shown in AA adolescents [16]. Simi-
larly, inverse relations between education and HDL-C
have been noted in AAs [17].
These findings may be considered consistent with the
"diminishing returns" hypothesis [18] which posits that
AAs may not benefit as much as Whites from higher
levels of socioeconomic resources. However, an alterna-
tive explanation is the known lack of equivalence of so-
cioeconomic resources in AAs and Whites. Specifically,
multiple SES-related variable differ systematically be-
tween AAs and Whites. For example, on average, AAs
obtain less quality education than Whites [19]. Further-
more, AAs have smaller incomes (and less wealth) than
Whites at each level of education [2]. Thus, SES measures
likely have differential validity within racial/ethnic groups.
Better understanding of respective influences of SES indi-
cators on CVD risk factors within AA and Whites is
needed.
Considered from the perspective of risk and resilience,
another possibility is that lower SES confers greater risk
in Whites than AAs with respect to BMI, WC, and
HDL-C, whereas the opposite is true for higher SES.
Complex explanatory mechanisms may differ within the
race and SES subgroups. For example, AAs below pov-
erty are more likely to suffer from food insecurity than
their White peers also below poverty, whereas there is
no difference between Whites and AAs above poverty
[20]. Thus, one must consider that the lower BMIs and
WCs among this group may, in part, reflect a larger pro-
portion of underweight persons. Further, in the present
sample, food insecurity was associated with worse diet
quality in Whites than AAs [21]. Within White women,
Montez and Zajakova [22] have reported increasing
levels of all-cause and CVD mortality associated with
lower levels of education in conjunction with declining
Table 2 Unstandardized regression coefficients and standard errors for all variables included in models examining anthropometric
outcome measures
Body Mass Index (mg/k2)
(n = 2270)
p Waist Circumference (cm)
(n =2270)
p
Age -0.02 (0.02) 0.273 0.05 (0.04) 0.186
Sex (0 = female; 1 =male) -1.08 (0.56) 0.054 4.18 (1.27) 0.001
Race (0 = White; 1 = AA) 1.80 (0.53) 0.001 2.90 (1.21) 0.017
Poverty Status (0 = non-poverty;1 = poverty) 1.35 (0.66) 0.041 3.00 (1.50) 0.046
Education -0.24 (0.06) 0.000 -0.57 (0.13) 0.000
WRAT-III Read Score 0.02 (0.02) 0.330 0.03 (0.05) 0.618
Cigarette Use -1.43 (0.21) 0.000 -2.47 (0.47) 0.000
Alcohol Use -0.29 (0.20) 0.141 -0.27 (0.45) 0.553
Cocaine Use -0.13 (0.34) 0.695 -0.26 (0.78) 0.743
Heroin Use -1.47 (0.40) 0.000 -3.82 (0.92) 0.000
Marijuana Use -0.34 (0.25) 0.182 -0.98 (0.58). 0.092
CES-D Score 0.01 (0.01) 0.582 0.05 (0.03) 0.157
Healthcare Barriers 0.03 (0.05) 0.546 -0.05 (0.11) 0.638
MIA Cormorbidity Cluster 0.96 (0.46) 0.036 2.59 (1.04) 0.013
CVD Comorbidity Cluster -0.48 (0.79) 0.539 1.20 (1.79) 0.504
Diabetes Medications 5.36 (0.53) 0.000 13.03 (1.20) 0.000
Race x Poverty Status -2.49 (0.84) 0.003 -7.82 (1.91) 0.000
Sex x Race -2.06 (0.78) 0.008 -7.46 (1.77) 0.000
Sex x Poverty Status -1.74 (1.03) 0.090 -3.95 (2.34) 0.091
Sexx Race x Poverty Status 1.15 (1.31) 0.377 2.70 (2.97) 0.364
AA = African American; WRAT-III = Wide Range Achievement Test third edition; CES-D = Center for Epidemiological Studies- Depression; MIA =metabolic/inflamma-
tory/autoimmune disease; CVD = cardiovascular disease
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Table 3 Unstandardized regression coefficients and standard errors for all variables included in models examining metabolic and inflammatory outcome measures
Total Cholesterol
(mg/dl) (n = 2134)
p HDL - Cholesterol
(mg/dl) (n = 2134)
p LDL-Cholesterol
(mg/dl) (n = 2134)
p Triglycerides
(mg/dl) (n = 2134)
p Glycated Hemoglobin
(%) (n = 2134)
p C-Reactive Protein
(mg/l) (n = 2069)
p
Age 0.62 (0.10) 0.000 0.21 (0 .04) 0.000 0.43 (0.09) 0.000 −0.37 (0.31) 0.233 0.01 (0.00) 0.000 0.02 (0.02) 0.517
Sex (0 = female; 1 =male) −10.57 (3.32) 0.002 −12.27 (1.23) 0.000 −4.43 (2.78) 0.111 39.15 (9.78) 0.000 0.07 (0.08) 0.423 −2.06 (0.77) 0.007
Race (0 =White; 1 = AA) −9.00 (3.15) 0.004 3.58 (1.16) 0.002 −6.04 (2.63) 0.022 −34.47 (9.26) 0.000 0.24 (0.08) 0.002 −0.41 (0.72) 0.569
Poverty Status (0 = non-
poverty;1 = poverty)
−5.08 (3.89) 0.192 −3.73 (1.44) 0.010 −3.62 (3.26) 0.266 15.06 (11.46) 0.189 −0.01 (0.10) 0.907 −0.77 (0.88) 0.383
Education −0.80 (0.35) 0.022 0.24 (0.13) 0.068 −0.58 (0.29) 0.046 −1.87 (1.03) 0.069 −0.02 (0.01) 0.072 −0.09 (0.08) 0.282
WRAT-III Read Score 0.08 (0.13) 0.532 −0.04 (0.05) 0.421 0.12 (0.11) 0.279 −0.19 (0.39) 0.625 0.00 (0.00) 0.424 −0.01 (0.03) 0.824
Cigarette Use −0.01 (1.25) 0.992 −2.42 (0.46) 0.000 1.08 (1.04) 0.301 12.07 (3.67) 0.001 −0.01 (0.03) 0.649 0.43 (0.29) 0.134
Alcohol Use −0.93 (1.18) 0.432 2.41 (0.44) 0.000 −2.95 (0.99) 0.003 −5.04 (3.47) 0.147 −0.03 (0.03) 0.356 −0.05 (0.28) 0.853
Cocaine Use 1.47 (2.04) 0.472 2.79 (0.76) 0.000 −1.96 (1.71) 0.253 1.14 (6.02) 0.846 −0.07 (0.05) 0.159 −0.49 (0.46) 0.288
Heroin Use −5.53 (2.45) 0.024 −0.54 (0.91) 0.554 −5.18 (2.05) 0.012 −3.25 (7.20) 0.651 0.03 (0.06) 0.645 0.67 (0.56) 0.230
Marijuana Use −0.28 (1.51) 0.855 0.29 (0.56) 0.603 0.46 (1.27) 0.719 −5.01 (4.45) 0.261 −0.03 (0.04) 0.484 0.08 (0.34) 0.807
CES-D Score −0.14 (0.09) 0.101 −0.02 (0.03) 0.481 −0.11 (0.07) 0.127 0.12 (0.25) 0.637 0.00 (0.00) 0.561 −0.02 (0.02) 0.269
Healthcare Barriers −0.04 (0.28) 0.876 −0.12 (0.10) 0.245 0.08 (0.24) 0.727 0.66 (0.83) 0.426 −0.02 (0.01) 0.007 −0.14 (0.06) 0.028
Body Mass Index −0.02 (0.13) 0.877 −0.67 (0.05) 0.000 0.37 (0.11) 0.000 1.73 (0.37) 0.000 0.02 (0.00) 0.000 0.30 (0.03) 0.000
MIA Cormorbidity Cluster −8.38 (2.73) 0.002 −2.83 (1.01) 0.005 −5.76 (2.28) 0.012 −2.23 (8.03) 0.781 −0.06 (0.07) 0.356 0.28 (0.61) 0.653
CVD Comorbidity Cluster −21.51 (4.82) 0.000 −4.42 (1.79) 0.013 −15.05 (4.03) 0.000 −13.43 (14.19) 0.344 −0.07 (0.12) 0.560 3.60 (1.06) 0.001
Antilipidemics 7.13 (2.74) 0.009 −2.10 (1.01) 0.039 1.27 (2.29) 0.580 53.78 (8.06) 0.000 0.22 (0.07) 0.001 −0.61 (0.62) 0.324
Diabetes Medications −7.12 (3.36) 0.035 −1.48 (1.25) 0.236 −11.33 (2.81) 0.000 35.18 (9.90) 0.000 2.16 (0.08) 0.000 0.10 (0.75) 0.893
Race x Poverty Status 2.57 (4.96) 0.604 3.94 (1.84) 0.032 1.71 (4.15) 0.680 −18.58 (14.60) 0.203 0.07 (0.12) 0.595 1.12 (1.14) 0.325
Sex x Race 7.33 (4.64) 0.115 1.88 (1.72) 0.274 6.76 (3.89) 0.082 −9.14 (13.67) 0.504 0.01 (0.11) 0.914 0.78 (1.06) 0.462
Sex x Poverty Status 4.69 (6.12) 0.443 3.78 (2.27) 0.095 1.69 (5.12) 0.741 17.51 (18.01) 0.331 0.17 (0.15) 0.268 1.05 (1.38) 0.446
Sex x Race x Poverty
Status
−5.93 (7.78) 0.446 1.38 (2.88) 0.633 −5.88 (6.51) 0.366 −30.08 (22.90) 0.189 −0.22 (0.19) 0.251 1.12 (1.77) 0.525














levels among the more highly educated. Better under-
standing of the sources of these secular trends may point
toward additional explanatory mechanisms.
Regarding those of higher SES, prior research has
shown that AAs tend to report greater stress and
discrimination than AAs of lower SES [23, 24]. Higher
cortisol levels that accompany stress have been associ-
ated with increased appetite [25], and may be a relevant
influence to consider. It is also well known that multiple
dimensions of neighborhoods, such as access to healthy
Table 4 Unstandardized regression coefficients and standard errors for all variables included in models examining hemodynamic
outcome measures
Systolic Blood Pressure
(mm Hg) (n = 2270)
p Diastolic Blood Pressure
(mm Hg) (n = 2270)
p Pulse Pressure (mm Hg)
(n = 2270)
p
Age 0.48 (0.04) 0.000 0.02 (0.03) 0.382 0.45 (0.03) 0.000
Sex (0 = female; 1 =male) 5.44 (1.23) 0.000 4.79 (0.80) 0.000 0.66 (0.89) 0.461
Race (0 = White; 1 = AA) 3.57 (1.17) 0.002 0.88 (0.76) 0.250 2.69 (0.85) 0.002
Poverty Status (0 = non-poverty; 1 = poverty) 0.41 (1.45) 0.779 1.42 (0.94) 0.133 −1.01 (1.05) 0.336
Education −0.25 (0.13) 0.050 −0.14 (0.08) 0.093 −0.11 (0.09) 0.230
WRAT-III Read Score −0.01 (0.05) 0.881 −0.01 (0.03) 0.827 −0.00 (0.04) 0.991
Cigarette Use −0.57 (0.46) 0.215 −0.81 (0.30) 0.007 0.24 (0.33) 0.464
Alcohol Use 0.29 (0.44) 0.511 0.35 (0.28) 0.216 −0.06 (0.32) 0.839
Cocaine Use 0.31 (0.75) 0.677 0.62 (0.49) 0.203 −0.31 (0.54) 0.570
Heroin Use −2.44 (0.89) 0.006 −1.27 (0.58) 0.029 −1.17 (0.64) 0.069
Marijuana Use 2.34 (0.56) 0.000 0.77 (0.36) 0.034 1.57 (0.41) 0.000
CES-D Score 0.01 (0.03) 0.840 0.01 (0.02) 0.782 0.00 (0.02) 0.975
Healthcare Barriers −0.03 (0.10) 0.749 −0.06 (0.07) 0.355 0.03 (0.08) 0.697
Body Mass Index 0.50 (0.05) 0.000 0.21 (0.03) 0.000 0.29 (0.03) 0.000
MIA Cormorbidity Cluster 0.44 (1.01) 0.659 −0.18 (0.65) 0.785 0.62 (0.73) 0.393
CVD Comorbidity Cluster −2.88 (1.74) 0.100 −2.98 (1.13) 0.009 0.11 (1.26) 0.932
Antihypertensives 4.87 (0.80) 0.000 3.01 (0.52) 0.000 1.85 (0.58) 0.001
Race x Poverty Status 2.27 (1.84) 0.218 0.75 (1.20) 0.530 1.52 (1.33) 0.255
Sex x Race −2.62 (1.71) 0.126 −0.36 (1.12) 0.745 −2.26 (1.24). 0.069
Sex x Poverty Status 0.15 (2.25) 0.947 −1.09 (1.47) 0.457 1.24 (1.63) 0.447
Sex x Race x Poverty Status −1.10 (2.86) 0.700 −1.55 (1.86) 0.404 0.45 (2.07) 0.828
WRAT-III = Wide Range Achievement Test third edition; CES-D = Center for Epidemiological Studies Depression; MIA =metabolic/inflammatory/autoimmune disease;
CVD = cardiovascular disease
Above Below










































































Fig. 1 Interactive relations of race and poverty status to body mass index, waist circumference, and HDL-cholesterol; predicted values and standard
errors after adjustment for age, education, literacy, substance use, depressive symptoms, perceived health care barriers, medical co-morbidities,
and medications
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food and walkability, differ systematically for AAs and
Whites even in the context of similar economic means
[2]. However, associated risks tend to be greater for AAs
than Whites. Examination of contextual influences spe-
cific to Baltimore City may be informative.
Distinct patterns of race associations (i.e., main ef-
fects of race) were found for six of the 11 risk factors -
SBP, PP, TC, LDL-C, TG, and HbA1c. AAs had higher
levels of SBP, PP, and HbA1c than Whites, whereas
Whites had higher levels of TC, LDL-C, and TG than
AAs. These findings are consistent with prior epi-
demiological studies which show that AAs have higher
blood pressure, and greater fasting glucose, HbA1c, and
risk for diabetes, but better cholesterol profiles than
Whites [1, 26, 27]. The present findings reinforce that
the above racial differences are not fully attributable to
poverty status, education, or literacy, substance use, de-
pressive symptoms, perceived healthcare barriers, co-
morbidities, and medication use (as measured herein).
However, more detailed measurement of these adjust-
ment variables (particularly substance use) is warranted
as residual confounding seems likely. Nonetheless, con-
tinued evaluation of additional possible mediational
pathways is needed. The present findings, and those in
the literature, may suggest a role for a dysfunctional
gene-environment interaction as well as the presence of
other factors relevant to the basic biology of disadvan-
tage and health disparities [28].
Intersection of race and SES
Race is a complex biopsychosocial and sociopolitical
construct [2, 7, 29] that reflects a multitude of influ-
ences ranging from geographic origin, ancestry, and
culture (e.g., ethnicity), in addition to economic, polit-
ical, and historical factors, environmental context, and
racism. That the HANDLS participants self-identified
as AA and White highlights the present view of race as
a social (not a biological) construct. In the present
study, associations of race with CVD risk remained
after adjustment for multiple potential confounders
and/or mediators. Vanderweele [29] offers an elegant
discussion of interpretation of covariate adjusted race
coefficients, highlighting the range of variables to which
one might attribute remaining race associations, e.g.,
genotype, phenotype, individual/family SES, neighbor-
hood SES. We suggest that the present findings further
reflect, at least in part, the pronounced environmental
and interpersonal stressors that are disproportionately
experienced by AAs. Indeed, racial disparities in health
have been shown to exist at every level of SES [2].
SES is another complex construct that has been
indexed in various ways, the most common of which
include measures of educational attainment, income,
occupation, occupational prestige, home and goods
ownership, and area-based resources [30, 31]. Each
measure confers its own strengths and weaknesses,
with none fully capturing the complexities of social dis-
advantage [30]. Further understanding of potentially
unique contributions of each measure to health status
may be important in the translation of research to
intervention and policy. In addition, each type of meas-
ure may operate differently with respect to moderating
(or partially mediating) relations of race/ethnicity to
health outcomes [32]. It is striking that, in the present
sample, poverty status (our primary SES indicator)
moderated relations of race to only three of 11 CVD
risk factors, presented greater risk for Whites than
AAs, and showed no additional main effects with re-
spect to these outcomes. However, findings may have
been quite different had we used education as our SES
indicator. Furthermore, prior work from HANDLS has
shown differential relations of subjective SES to CVD
risk profile in AAs and Whites [33]. Future work
should contrast the respective (and cumulative) influ-
ences of distinct SES indicators in addition to specific-
















































Fig. 2 Interactive relations of race and sex to body mass index and waist circumference: predicted values and standard errors after adjustment for
age, education, literacy, substance use, depressive symptoms, perceived health care barriers, medical co-morbidities, and medications
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Both race and SES likely index many similar exposures to
challenging environmental and psychosocial contexts [2,
34–36] that negatively impact health status. Yet, it remains
unclear what health compromising (or health promoting)
dimensions of self-identified race are distinct from SES and,
conversely, what influences of SES are separate from race.
We agree with Williams et al. [2] that the independent in-
fluences of race and SES on disease probably cannot be
fully disentangled. However, future research could use vari-
ous statistical methods to construct complex pathways
from race and SES to disease outcomes [29].
Clear correlates of race include racism and discrimin-
ation [2]; yet, even those influences may vary by SES and
sex. Various other mechanistic pathways to CVD out-
comes may differ for AA and White men and women of
higher versus lower SES. Increased consideration of such
intersectionality has been strongly advised. Williams et al.
[2] further note that multiple dimensions of social in-
equality, other than SES indicators, differ between AAs
and Whites. These complex pathways range from micro-
to macro- level factors. Macro level influences have been
discussed thoroughly with examples including institu-
tional racism, historical oppression, and access to quality
health care. Relevant neighborhood characteristics include
racial segregation, access to healthy food and green space,
exposure to environmental toxins, pollution, noise, crowd-
ing, neighborhood physical and social disorder, and crime.
Both race and SES may further impact multiple psy-
chosocial, lifestyle, psychophysiological, and biological
factors (e.g., [2, 34–36]) such as social integration, so-
cial support, perceived stress, vigilance, anger, anxiety,
symptoms of depression and post-traumatic stress dis-
order, substance use topography, physical activity, diet-
ary patterns and preferences, sleep, stress physiology
(e.g., autonomic, neuroendocrine, and immune func-
tion), and epigenetics.
Study strengths and limitations
The present investigation has several notable strengths.
First, the HANDLS study was explicitly designed to dis-
entangle respective influences of self-identified AA and
White race from poverty status, and provided a large
and diverse sample of men and women that supported
explicit examination of race, poverty status, and sex in-
teractions. Second, our inclusion of multiple relevant
adjustment variables suggests that the influences of race
and poverty status on CVD risk may extend beyond edu-
cation, literacy, substance use, depression, access to
healthcare and select medical co-morbidities.
The current work also has important limitations. In
that regard, the findings do not generalize to ethnic
minority populations other than AAs. Furthermore, the
results may be unique to the urban environment of
Baltimore city. Importantly, only crude measures of
health habits were obtained. More detailed information
about the topography of smoking, alcohol, and illicit
drug use should be informative in future work. We also
did not have a physical activity measure. Next, although
this work addressed the influence of poverty independ-
ent of education and literacy, we did not contrast re-
spective influences of these SES indicators. Further,
these SES factors may work in concert suggesting that
future work should evaluate their combined influence.
In addition, we did not have a full spectrum of SES in-
dicators including occupational status or wealth. We
did not test whether our adjustment variables operated
as partial mediators of the relations of race and/or pov-
erty status to CVD risk. Our CRP samples were assayed
by two different institutions; although an internal reli-
ability study was computed at the time of change, the
associated data are not available. Our AA sample in-
cluded a proportionally larger group of persons living
in poverty than our White sample. Another limitation
is the amount of missing data for each of the outcome
variables. Lastly, we computed multiple comparisons
without associated adjustment of p values; thus, the
present findings (particularly interactions) should be
interpreted with caution. In that regard, it is unlikely
that the present sample is sufficiently large to support
reasonable power for examining all of our interactions.
Replication is necessary to establish firmer evidence for
these effects. In addition, it will be important to examine
whether noted associations differ as a function of age.
Conclusion
Further understanding of the interactive and independ-
ent relations of race and SES to CVD risk factors, and
their relevant underlying mechanisms, is critical to de-
velopment of individual level and community based pre-
vention and intervention efforts, in addition to relevant
policy. The present findings suggest that poverty confers
differential risk for higher BMI and WC, and lower
HDL-C, among AAs and Whites. Elucidation of com-
plex, multi-level mediators of these differential associa-
tions is needed as patterns of risk and resilience may
vary within these subgroups of persons. The present
findings further suggest that race-related patterns of
CVD risk - better lipid profiles, but higher HbA1c and
blood pressure in AAs compared to Whites – are not
fully explained by a host of SES, behavioral, psychosocial,
and biomedical adjustment variables. Continued identifi-
cation of the micro-to-macro level mechanisms under-
lying these race differences will be critical to the
elimination of health disparities. Future work would
benefit from use of path analysis or structural equation
modeling to explore whether mediational pathways differ
among AA and White men and women who vary in
SES.
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